title: Analysis of the potential carcinogenicity of coffee and its related compounds in a medium-term liver bioassay of rats.
abstract: The potential carcinogenicity of coffee and related compounds was examined using a medium-term liver bioassay based on the induction of glutathione S-transferase placental form (GST-P)-positive foci in F344 rats. A total of 230 males were initially injected with diethylnitrosamine (200 mg/kg body weight, ip) or saline as controls and 2 wk later were fed on diet or drinking water supplemented as follows for 6 wk: 5% regular instant coffee; 5% decaffeinated instant coffee; freshly brewed coffee, 8 g in 140 ml water; 0.1% caffeine, 0.2% methylglyoxal, 0.2% glyoxal; or 0.3% theophylline in the drinking water (w/v); and 0.4% theobromine in the diet (w/w). All rats were subjected to two-thirds partial hepatectomy at wk 3 and killed at wk 8. The resultant values for GST-P-positive hepatic focus induction were slightly increased with methylglyoxal and decreased with glyoxal and theobromine compared with the corresponding controls. Although the increase in number of foci for methylglyoxal was statistically significant at P < 0.05, the value was within the historical control levels. Regular and decaffeinated instant coffee as well as fresh-brewed coffee, caffeine and theophylline exerted no effects on focus development. Thus, the coffee-related compounds examined demonstrated no obvious enhancing potential, and it is therefore concluded that coffee and its main constituents are not carcinogenic for the rat liver.
authors: First Department of Pathology, Nagoya City University Medical School, Japan.
authors: R
authors: R
authors: Hasegawa
authors: T
authors: T
authors: Ogiso
authors: K
authors: K
authors: Imaida
authors: T
authors: T
authors: Shirai
authors: N
authors: N
authors: Ito
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001681:Biological Assay; D001835:Body Weight / Q000187:drug effects; D002110:Caffeine / Q000008:administration & dosage / Q000633:toxicity; D003069:Coffee / Q000633:toxicity*; D004052:Diethylnitrosamine / Q000633:toxicity; D005982:Glutathione Transferase / Q000032:analysis; D006037:Glyoxal / Q000008:administration & dosage / Q000633:toxicity; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008113:Liver Neoplasms / Q000139:chemically induced / Q000209:etiology*; D008297:Male; D009929:Organ Size / Q000187:drug effects; D011765:Pyruvaldehyde / Q000008:administration & dosage / Q000633:toxicity; D051381:Rats; D011916:Rats, Inbred F344; D013805:Theobromine / Q000008:administration & dosage / Q000633:toxicity; D013806:Theophylline / Q000008:administration & dosage / Q000633:toxicity
chemical_list: D003069:Coffee; D002110:Caffeine; D004052:Diethylnitrosamine; D006037:Glyoxal; D011765:Pyruvaldehyde; D013806:Theophylline; D005982:Glutathione Transferase; D013805:Theobromine